Notice of Delisting or Failure to Satisfy a Continued Listing Rule
→
7/23/25
Delisting
Notice of Delisting or Failure to Satisfy a Continued Listing Rule
→
7/16/25
Other
Termination of a Material Definitive Agreement
→
6/13/25
Other
Termination of a Material Definitive Agreement
→
4/23/25
Delisting
Notice of Delisting or Failure to Satisfy a Continued Listing Rule
→
4/1/25
Vote
Submission of Matters to a Vote of Security Holders
→
↓
Prospectuses & Registrations
12 shown
Filed
Form
Description
8/16/23
424B3
424B3
→
8/16/23
424B3
424B3
→
8/3/23
424B3
424B3
→
7/6/23
S-1/A
S-1/A
→
6/23/23
424B3
424B3
→
6/22/23
S-1
S-1
→
↓
Filing History(255 filings)
TypeDateAccessionPeriodSize
NT 10-Q
Aug 14, 2025
0001641172-25-023734NT 10-Q
Jun 30, 2025
39.4 KB
25-NSE
Aug 8, 2025
0001354457-25-000798
—
4.3 KB
8-K
Aug 5, 2025
0001641172-25-0222718-K
Jul 31, 2025
248.4 KB
8-K
Jul 23, 2025
0001641172-25-0207308-K
Jul 17, 2025
187.4 KB
8-K
Jul 16, 2025
0001641172-25-0199248-K
Jul 10, 2025
245.4 KB
8-K
Jun 13, 2025
0001641172-25-0151298-K
Jun 12, 2025
197.3 KB
10-Q
May 15, 2025
0001641172-25-01108010-Q
Mar 31, 2025
6.1 MB
10-K/A
Apr 29, 2025
0001641172-25-006669ANNUAL REPORT
Dec 31, 2024
532.1 KB
8-K
Apr 23, 2025
0001641172-25-005788
Apr 22, 2025
228.9 KB
10-K
Apr 8, 2025
0001641172-25-003155
Dec 31, 2024
11.7 MB
8-K
Apr 1, 2025
0001641172-25-002074
Mar 28, 2025
275.0 KB
NT 10-K
Apr 1, 2025
0001641172-25-002034
Dec 31, 2024
34.6 KB
8-K
Mar 26, 2025
0001641172-25-000747
Mar 26, 2025
252.1 KB
8-K
Mar 20, 2025
0001493152-25-011046
Mar 14, 2025
254.2 KB
DEFA14A
Mar 10, 2025
0001493152-25-009713
—
28.6 KB
8-K
Mar 10, 2025
0001493152-25-009707
Mar 4, 2025
258.8 KB
8-K
Feb 26, 2025
0001493152-25-008395
Feb 20, 2025
28.3 MB
DEF 14A
Feb 26, 2025
0001493152-25-008279
Feb 26, 2025
671.7 KB
8-K
Feb 21, 2025
0001493152-25-007933
Feb 21, 2025
253.7 KB
PRE 14A
Feb 14, 2025
0001493152-25-006994
Feb 14, 2025
670.2 KB
SCHEDULE 13G/A
Feb 13, 2025
0001493152-25-006338
—
11.8 KB
8-K
Feb 12, 2025
0001493152-25-006180
Feb 11, 2025
254.5 KB
8-K
Jan 15, 2025
0001493152-25-002237
Jan 7, 2025
260.6 KB
10-Q
Jan 13, 2025
0001493152-25-001880
Sep 30, 2024
7.7 MB
10-Q
Dec 23, 2024
0001493152-24-051208
Jun 30, 2024
10.9 MB
25 filings shown
Proxies
10 shown
Filed
Form
Description
3/10/25
DEFA14A
DEFA14A
→
2/26/25
DEF 14A
DEF 14A
→
2/14/25
PRE 14A
PRE 14A
→
8/4/23
DEF 14A
DEF 14A
→
7/24/23
PRE 14A
PRE 14A
→
1/25/23
DEFR14A
DEFR14A
→
↓
Ownership
40 shown
Filed
Form
Description
2/14/24
SC 13G
SC 13G
→
2/14/24
SC 13G/A
SC 13G/A
→
2/13/24
SC 13G/A
SC 13G/A
→
2/13/24
SC 13G/A
SC 13G/A
→
2/12/24
SC 13G/A
SC 13G/A
→
2/9/24
SC 13G/A
OCEAN BIOMEDICAL INC 13GA
→
↓
Other Filings
34 shown
Filed
Form
Description
8/8/25
25-NSE
25-NSE
→
2/13/25
SCHEDULE 13G/A
SCHEDULE 13G/A
→
7/7/23
EFFECT
EFFECT
→
6/22/23
EFFECT
EFFECT
→
6/15/23
D
D
→
2/15/23
25-NSE
25-NSE
→
↓
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.